House of Commons Debate – Medicines and Healthcare Products Regulatory Agency (16 January 2025)

Summary

This was a debate in the House of Commons on the 16 January 2025 discussing the performance of the Medicines and Healthcare products Regulatory Agency (MHRA), the body responsible for the regulation of medicines and medical devices in the UK. The motion debated focused on the MHRA’s performance in relation to patient safety matters, including: the agency’s work on the hormone pregnancy tests, the Yellow Card System and safety monitoring, funding and the influence of the pharmaceutical industry and the implementation of recommendations made by the Independent Medicines and Medical Devices Safety review.